Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €2.70 EUR
Change Today -0.10 / -3.57%
Volume 253.0K
As of 8:37 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

sorin spa (SRN) Snapshot

Open
€2.74
Previous Close
€2.80
Day High
€2.77
Day Low
€2.70
52 Week High
03/6/15 - €3.07
52 Week Low
10/15/14 - €1.63
Market Cap
1.3B
Average Volume 10 Days
1.8M
EPS TTM
€0.07
Shares Outstanding
478.7M
EX-Date
--
P/E TM
39.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for SORIN SPA (SRN)

Related News

No related news articles were found.

sorin spa (SRN) Related Businessweek News

No Related Businessweek News Found

sorin spa (SRN) Details

Sorin S.p.A., together with its subsidiaries, researches, develops, and delivers various therapeutic solutions to treat cardiovascular pathologies. It operates through Cardiac Surgery and Cardiac Rhythm Management (CRM) business units. The company provides disposable biomedical devices and systems, including heart-lung machines, oxygenators, autotransfusion systems and devices, mechanical heart valves, tissue heart valves, structureless valves, and annuloplasty rings for extracorporeal circulation during surgery. It also provides defibrillators and pacemakers, and systems for cardiac resynchronisation treatment, patient management, and cardiac arrhythmia assessment. In addition, the company offers single-use systems for urology, urodynamics, cardiac surgery, and haemodialysis. It serves hospitals, healthcare institutions, distributors, organised purchase groups, and government and private entities in Italy, rest of Europe, North America, and internationally. The company was incorporated in 2004 and is headquartered in Milan, Italy.

3,940 Employees
Last Reported Date: 07/31/15
Founded in 2004

sorin spa (SRN) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: €713.0K
Chairman, President and Chairman of Executive...
Total Annual Compensation: €629.0K
Compensation as of Fiscal Year 2014.

sorin spa (SRN) Key Developments

Sorin Group Announces European Launch of REPLY CRT-P

Sorin Group announced the launch of REPLY CRT-P, its new cardiac resynchronization therapy pacemaker. The REPLY CRT-P with its 11.3 cc in volume is the smallest cardiac resynchronization pacemaker in the world. It features proprietary algorithms aimed at better supporting heart failure management and ultimately improving patient outcome. The Sleep Apnea Monitoring (SAM) algorithm detects severe sleep apnea using a highly reliable sensor that measures ventilation. The index reported by the device has been validated against polysomnography, the gold standard method used to diagnose sleep apnea, yielding a high specificity of 85% and a sensitivity of 89%. Data from HF population studies suggest that both obstructive sleep apnea as well as central sleep apnea may be present in 30% to 50% of HF patients. If left untreated, sleep apnea increases the risk of death and HF hospitalization. SAM can screen these patients for severe sleep apnea so that they can be treated. In addition, it can be used to monitor the long term progression of the disease.

Sorin SpA Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Sorin SpA reported consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, revenues were €215.6 million, up 5.2% at comparable foreign exchange and 13.1% as reported compared to the second quarter of 2014. Adjusted net profit was €16.5 million, up 47.0% compared to €11.2 million in the second quarter of 2014, including a €1.6 million impact from New Ventures and a €1.8 million unfavorable foreign exchange effect. EBITDA was €32.7 million (15.1% of revenues), up 14.3% compared to €28.6 million (15.0% of revenues) in the second quarter of 2014. EBIT was €1.1 million compared to €15.8 million in the second quarter of 2014. EBIT before special items was €18.6 million, up 10.3% compared to €16.9 million in the second quarter of 2014. In the second quarter of 2015, the Company’s free cash flow was €17.8 million. For the six months, revenues were €405.0 million, up 3.0% at comparable foreign exchange and 10.4% as reported compared to the first half of 2014. Adjusted net profit was €24.2 million, up 8.1% compared to €22.4 million in the first half of 2014, including a €3.4 million impact from New Ventures and a €5.2 million unfavorable foreign exchange effect. EBITDA was €57.3 million (14.2% of revenues) up 3.5% compared to €55.4 million (15.1% of revenues) in the first half of 2014. EBIT was €3.0 million compared to €30.1 million in first half of 2014. EBIT before special items was €30.5 million compared to €32.4 million in the first half of 2014. Net profit was €0.6 million compared to €19.9 million in the first half of 2014. Net financial debt as of June 30, 2015 totaled €153.4 million. In the first half of 2015 the Company’s free cash flow was €2.0 million.

Sorin Launches New Generation of Heating and Cooling Systems

Sorin Group has launched the new generation of heating and cooling systems, FlexTherm. A simple, display-guided disinfection procedure, which includes a reminder function, reduces operator time and provides maximum protection against bacteria. The new process takes only 35 minutes operator time once every 14 days. The safe and effective, display-guided procedure eliminates the risk for errors. Streamlining the disinfection process maximizes safety for the patients against infections and reduces the time dedicated to disinfection, helping decrease the overall cost of care for hospitals. FlexTherm is equipped with three water tanks, each with a different temperature setting, allocated to three independent water circuits. This design enables superior temperature control and maximum flexibility for use in various simultaneous applications. Precise water flow measurement ensures efficacy and increased control in energy transfer when heating and cooling the patient.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRN:IM €2.70 EUR -0.10

SRN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $193.79 USD -3.68
Edwards Lifesciences Corp $140.88 USD -3.82
Smith & Nephew PLC 1,138 GBp -25.00
Stentys €5.50 EUR -0.15
Zimmer Biomet Holdings Inc $103.56 USD -0.81
View Industry Companies
 

Industry Analysis

SRN

Industry Average

Valuation SRN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 16.9x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SORIN SPA, please visit www.sorin.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.